Human medicines European public assessment report (EPAR): Vgenfli, aflibercept, Status: Opinion
Human medicines European public assessment report (EPAR): Vgenfli, aflibercept, Status: Opinion
Human medicines European public assessment report (EPAR): Vgenfli, aflibercept, Status: Opinion
Summary of opinion: Benlysta, 19/06/2025 Positive
Summary of opinion: Sarclisa, 19/06/2025 Positive
Summary of opinion: Imbruvica, 19/06/2025 Positive
New stem cell therapy to treat patients with blood cancers
Summary of opinion: Nubeqa, 19/06/2025 Positive
Summary of opinion: Darzalex, 19/06/2025 Positive
Orphan designation: haematopoietic stem cells and blood progenitors umbilical cord-derived expanded with (1R, 4R)-N1-(2-benzyl-7-(2-methyl-2H-tetrazol-5-yl)-9H-pyrimido[4,5-b]indol-4-yl)cyclohexane-1,4-diamine dihydrobromide dihydrate Treatment in haematopoietic stem cell transplantation, 20/04/2020 Positive
EMEA-003599-PIP01-24
First treatment against liver scarring caused by a type of ‘fatty liver disease’